Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRX.L Regulatory News (CRX)

  • There is currently no data for CRX

Rule 8.3 - Cyprotex

3 Mar 2010 10:06

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code)

1. KEY INFORMATION

Name of person dealing (Note 1) R E Sneller Company dealt in Cyprotex Class of relevant security to Ord 0.1p share

which the dealings being disclosed relate (Note 2) Date of dealing 02/03/2010

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 6,500,000 (3.63%) (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total 6,500,000 (3.63%)

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options)

(3) Options and agreements to purchase/sell Total

(c) Rights to subscribe (Note 3)

Class of relevant security: Details 3. DEALINGS (Note 4)(a) Purchases and salesPurchase/sale Number of securities Price per unit (Note 5) Purchase 500,000 3.75p

(b) Derivatives transactions (other than options)

Product name, Long/short (Note Number of securities Price per unit (Note 6) (Note 7) 5) e.g. CFD

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name, Writing, Number of Exercise Type, e.g. Expiry Option

selling, securities to American, money e.g. call purchasing, which the price European date option varying option etc. paid/ etc. relates (Note received 7) per unit (Note 5) (ii) ExercisingProduct name, e.g. call Number of securities Exercise price per unit option (Note 5)

(d) Other dealings (including new securities) (Note 4)

Nature of transaction Details Price per unit (if (Note 8) applicable) (Note 5) 4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) YES/NO

Date of disclosure 03/03/2010 Contact name R E Sneller Telephone number 0131-275-2198

If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection (Note 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

vendor
Date   Source Headline
14th Dec 20164:03 pmRNSScheme of Arrangement becomes effective
14th Dec 20167:30 amRNSSuspension - Cyprotex Plc
13th Dec 20163:32 pmRNSDirector Dealing
13th Dec 201611:46 amRNSCourt Sanction of Scheme of Arrangement
9th Dec 20169:38 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
7th Dec 201610:02 amRNSForm 8.5 (EPT/RI) Cyprotex plc
6th Dec 20169:04 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
5th Dec 20166:34 pmRNSForm 8.3 - Cyprotex PLC
5th Dec 20166:34 pmRNSForm 8.3 - Cyprotex Plc
5th Dec 20169:12 amRNSForm 8.3 - Cyprotex PLC
2nd Dec 20161:45 pmRNSForm 8.3 - Cyprotex PLC
2nd Dec 20161:37 pmRNSForm 8.3 - Cyprotex PLC
2nd Dec 20168:45 amRNSForm 8.3 - Cyprotex PLC
1st Dec 20161:40 pmRNSResults of Court Meeting & General Meeting
1st Dec 20169:08 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
1st Dec 20168:23 amRNSForm 8.3 - Cyprotex PLC
30th Nov 20169:06 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
29th Nov 201610:31 amRNSForm 8.3 - CYPROTEX PLC
29th Nov 20169:46 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
29th Nov 20167:00 amRNSLaunch of in vitro h-CLAT Service
28th Nov 201610:52 amRNSForm 8.3 - CYPROTEX PLC
28th Nov 20169:18 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
25th Nov 20169:04 amRNSForm 8.5 (EPT/RI) Cyprotex plc
23rd Nov 20169:17 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
22nd Nov 20169:05 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
21st Nov 20169:04 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
16th Nov 20169:24 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
15th Nov 20168:39 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
14th Nov 20169:38 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
11th Nov 20167:00 amRNSDirector Dealing
10th Nov 20169:18 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
9th Nov 20169:53 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
8th Nov 201610:01 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
7th Nov 20169:27 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
4th Nov 20167:00 amRNSPosting of Scheme Document
2nd Nov 201610:09 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
1st Nov 20169:09 amRNSForm 8.5 (EPT/RI) Cyprotex
27th Oct 201612:39 pmRNSForm 8.5 (EPT/RI) CYPROTEX PLC
27th Oct 201610:11 amPRNForm 8.3 - Cyprotex Plc - Amendment
26th Oct 20169:08 amRNSForm 8.5 (EPT/RI) CYPROTEX PLC
26th Oct 20167:00 amRNSRule 2.7 Announcement: Recommended Offer
25th Oct 20169:23 amRNSForm 8.5 (EPT/RI) CYPROTEX PLC
21st Oct 20163:31 pmRNSDirector Declaration
21st Oct 20169:59 amRNSForm 8.5 (EPT/RI) CYPROTEX PLC
20th Oct 20168:57 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
18th Oct 20169:22 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
14th Oct 20169:16 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
13th Oct 20169:46 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
13th Oct 20167:00 amRNSCyprotex PLC - Rule 2.9 Announcement
11th Oct 20169:19 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.